investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Metabolism, Protein and miRNA Cross-Talk in Cell Cycle and Tumor Progression
David M Hockenbery
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Marc Nicklaus
Synthetically Accessible Virtual Inventory (SAVI)
All cancers but non-melanoma skin cancer
Scott Atwood
aPKC function in Hedgehog signaling and basal cell carcinoma
All cancers but non-melanoma skin cancer
Pathology
Mare Cudic
Novel Synthetic Tools for Mucin Glycobiology
All cancers but non-melanoma skin cancer
Steven C Pruitt
Replication Licensing in Genome Stability, Cancer and Aging
All cancers but non-melanoma skin cancer
Frank S Lee
Molecular Mechanisms of the Hypoxic Response
All cancers but non-melanoma skin cancer
Brian C Freeman
The Hsp90 Molecular Chaperone System
All cancers but non-melanoma skin cancer
Christopher A French
Pathogenesis and Treatment of NUT-Midline Carcinoma
All cancers but non-melanoma skin cancer
Naoto Hirano
Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy
All cancers but non-melanoma skin cancer
Sarah Hughes
CRC Tier 2 - Understanding how Merlin acts as a tumour suppressor
All cancers but non-melanoma skin cancer